"uuid:ID","name","text","label","id","description","instanceType"
"231fe577-f760-4530-9ead-78b7700e55eb","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","","Objective_1","Main objective","Objective"
"867057c9-27b7-4f26-af01-aea1d799a948","OBJ2","To document the safety profile of the xanomeline TTS.","","Objective_2","Safety","Objective"
"06b65bb5-5a7a-449e-9b9a-fcd864ca0112","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","","Objective_3","Behaviour","Objective"
